×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP ...
PR Newswire
PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on...
5 days ago
Palatin (PTN) Jumps: Stock Rises 8.7%
Yahoo Movies Canada
Palatin Technologies, Inc. PTN was a big mover last session, as the company saw its shares rise nearly 9% on the day.
1 day ago
Palatin Technologies (NYSEAMERICAN:PTN) Stock Rating Reaffirmed by HC Wainwright
Defense World
Read Palatin Technologies (NYSEAMERICAN:PTN) Stock Rating Reaffirmed by HC Wainwright at Defense World.
2 days ago
Palatin Technologies Shares Jump After Database Lock of Dry Eye Disease Drug Study
MarketWatch
By Zaeem Shoaib Shares of Palatin Technologies rose after the company announced that the database had been locked for the data of its phase...
3 months ago
Palatin to push through with dry eye therapy despite Phase III miss
Clinical Trials Arena
Palatin's dry eye therapy PL9643 failed to meet endpoints in the Phase III trial without statistical adjustments.
2 months ago
Palatin Technologies, Inc. (PTN) Reports Q3 Loss, Tops Revenue Estimates
Yahoo News Singapore
Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of -6.78% and 9.73%, respectively, for the quarter ended March...
5 days ago
Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in ...
PR Newswire
PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on...
1 week ago
Palatin Technologies Shares Rise 27% After Positive Trial Results for PL9643
MarketWatch
By Chris Wack Palatin Technologies shares were up 27% to $2.24 after the company said it saw positive topline results for its Phase 3...
1 month ago
Palatin Technologies, Inc. (AMEX:PTN) Q2 2024 Earnings Call Transcript
Yahoo Finance
Palatin Technologies, Inc. (AMEX:PTN) Q2 2024 Earnings Call Transcript February 15, 2024 Palatin Technologies, Inc. misses on earnings...
2 months ago
Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million
PR Newswire
PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on...
4 months ago